A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma (Q43152531)
Jump to navigation
Jump to search
scientific article published on 23 February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma |
scientific article published on 23 February 2010 |
Statements
1 reference
A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma (English)
1 reference
Susan Bates
1 reference
Tito Fojo
1 reference
Maureen Edgerly
1 reference
Hui Huang
1 reference
Michael Menefee
1 reference
Sen Zhuang
1 reference
Herb Kotz
1 reference
Marianne Poruchynsky
1 reference
Lyn Mickley Huff
1 reference
23 February 2010
1 reference
1 reference
16
1 reference
5
1 reference
1634-1641
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference